Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture
作者： Lee A. Jennings , Andrew D. Auerbach , Judith Maselli , Penelope S. Pekow , Peter K. Lindenauer
DOI: 10.1111/J.1532-5415.2010.02769.X
关键词:
摘要: OBJECTIVES: Although osteoporosis treatment can dramatically reduce fracture risk, rates of after hip remain low. In-hospital initiation recommended medications has improved outcomes in heart disease; hospitalization for may represent a similar opportunity improvement. The objective this study was to examine in-hospital with combination calcium and vitamin D (Cal+D) antiresorptive or bone-forming patients hospitalized fractures DESIGN: Observational cohort. SETTING: Three hundred eighteen hospitals the United States. PARTICIPANTS: Fifty-one thousand three forty-six aged 65 older osteoporotic fracture. MEASUREMENTS: administration Cal+D medications. RESULTS: four five (6.6%) received anytime procedure correct femoral fracture; 3,763 (7.3%) medications. Only 1,023 (2.0%) were prescribed ideal therapy, receiving an medication. Treatment remained low across virtually all patient-, provider-, hospital-level characteristics. strongest predictor receipt medication (adjusted odds ratio=5.50, 95% confidence interval=4.84–6.25), but only 27.2% who these also Cal+D. CONCLUSION: Rates are improve care.
unirioja.es
cabdirect.org
sci-hub.se 参考文章(41)
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, Osteoporosis Prevention, Diagnosis, and Therapy JAMA: The Journal of the American Medical Association. ,vol. 285, pp. 785- 795 ,(2001) , 10.1001/JAMA.285.6.785
Adrianne C. Feldstein, William M. Vollmer, David H. Smith, Amanda Petrik, Jennifer Schneider, Harry Glauber, Michael Herson, An Outreach Program Improved Osteoporosis Management After a Fracture Journal of the American Geriatrics Society. ,vol. 55, pp. 1464- 1469 ,(2007) , 10.1111/J.1532-5415.2007.01310.X
Suzanne M Cadarette, M Alan Brookhart, Niteesh K Choudhry, Margaret R Stedman, Margaret R Stedman, Daniel H Solomon, Jeffrey N Katz, Raisa Levin, Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. The Journal of Rheumatology. ,vol. 35, pp. 319- 326 ,(2008)
Dana Bliuc, Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women JAMA. ,vol. 301, pp. 513- 521 ,(2009) , 10.1001/JAMA.2009.50
Joseph B Muhlestein, Benjamin D Horne, Tami L Bair, Qunyu Li, Troy E Madsen, Robert R Pearson, Jeffrey L Anderson, Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality American Journal of Cardiology. ,vol. 87, pp. 257- 261 ,(2001) , 10.1016/S0002-9149(00)01354-0
VINCENT CAREY, SCOTT L. ZEGER, PETER DIGGLE, Modelling multivariate binary data with alternating logistic regressions Biometrika. ,vol. 80, pp. 517- 526 ,(1993) , 10.1093/BIOMET/80.3.517
Dawn C Mackey, Li-Yung Lui, Peggy M Cawthon, Douglas C Bauer, Michael C Nevitt, Jane A Cauley, Teresa A Hillier, Cora E Lewis, Elizabeth Barrett-Connor, Steven R Cummings, Study of Osteoporotic Fractures (SOF, High-Trauma Fractures and Low Bone Mineral Density in Older Women and Men JAMA. ,vol. 298, pp. 2381- 2388 ,(2007) , 10.1001/JAMA.298.20.2381
Frederick Hooven, Stephen H. Gehlbach, Penelope Pekow, Elizabeth Bertone, Evan Benjamin, Follow-up treatment for osteoporosis after fracture Osteoporosis International. ,vol. 16, pp. 296- 301 ,(2005) , 10.1007/S00198-004-1676-4
Joel F. Farley, Richard R. Cline, Kiran Gupta, Racial variations in antiresorptive medication use: results from the 2000 Medical Expenditure Panel Survey (MEPS) Osteoporosis International. ,vol. 17, pp. 395- 404 ,(2006) , 10.1007/S00198-005-2027-9
L. Giangregorio, A. Papaioannou, A. Cranney, N. Zytaruk, J.D. Adachi, Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon Seminars in Arthritis and Rheumatism. ,vol. 35, pp. 293- 305 ,(2006) , 10.1016/J.SEMARTHRIT.2005.11.001